Methods are provided for treating cancers that have high glucose requirements and that express SGLT2 at levels higher than normal cells, such as metastatic cancers, for example, metastatic lung cancers, employing an SGLT2 inhibitor alone or in combination with a cytotoxic agent and to a composition containing a combination of an SGLT2 inhibitor and a cytotoxic agent.
提供了一种治疗高
葡萄糖需求并且表达SGLT2
水平高于正常细胞的癌症的方法,例如转移性癌症,如转移性肺癌,使用单独或与细胞毒剂联合使用的SGLT2
抑制剂,并提供了一种包含SGLT2
抑制剂和细胞毒剂的组合物。